Literature DB >> 26762738

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.

Peter Goldstraw1, Kari Chansky2, John Crowley2, Ramon Rami-Porta3, Hisao Asamura4, Wilfried E E Eberhardt5, Andrew G Nicholson6, Patti Groome7, Alan Mitchell2, Vanessa Bolejack2.   

Abstract

The IASLC Staging and Prognostic Factors Committee has collected a new database of 94,708 cases donated from 35 sources in 16 countries around the globe. This has now been analysed by our statistical partners at Cancer Research And Biostatistics and, in close collaboration with the members of the committee proposals have been developed for the T, N, and M categories of the 8th edition of the TNM Classification for lung cancer due to be published late 2016. In this publication we describe the methods used to evaluate the resultant Stage groupings and the proposals put forward for the 8th edition. Crown
Copyright © 2015. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lung cancer; Prognostic factors; Staging

Mesh:

Year:  2016        PMID: 26762738     DOI: 10.1016/j.jtho.2015.09.009

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  1032 in total

1.  Evidence for Expanding Invasive Mediastinal Staging for Peripheral T1 Lung Tumors.

Authors:  Emily A DuComb; Benjamin A Tonelli; Ya Tuo; Bernard F Cole; Vitor Mori; Jason H T Bates; George R Washko; Raúl San José Estépar; C Matthew Kinsey
Journal:  Chest       Date:  2020-06-26       Impact factor: 9.410

2.  Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful?

Authors:  Jefree J Schulte; Jamie Steinmetz; Larissa V Furtado; Aliya N Husain; Mark W Lingen; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2020-04-29

3.  Epithelial-to-mesenchymal transition of A549 lung cancer cells exposed to electronic cigarettes.

Authors:  Atena Zahedi; Rattapol Phandthong; Angela Chaili; Guadalupe Remark; Prue Talbot
Journal:  Lung Cancer       Date:  2018-06-15       Impact factor: 5.705

Review 4.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

5.  Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.

Authors:  Yonggang Yuan; Ge Ma; YaQi Zhang; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2018-02-01       Impact factor: 4.553

6.  A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients.

Authors:  Elena Martínez-Terroba; Carmen Behrens; Fernando J de Miguel; Jackeline Agorreta; Eduard Monsó; Laura Millares; Cristina Sainz; Miguel Mesa-Guzman; José Luis Pérez-Gracia; María Dolores Lozano; Javier J Zulueta; Ruben Pio; Ignacio I Wistuba; Luis M Montuenga; María J Pajares
Journal:  J Pathol       Date:  2018-06-20       Impact factor: 7.996

7.  Implications of Preoperative Transbronchial Lung Biopsy for Non-small Cell Lung Cancer Less than 3-cm.

Authors:  Motoaki Yasukawa; Takeshi Kawaguchi; Michitaka Kimura; Takashi Tojo; Shigeki Taniguchi
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

8.  A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.

Authors:  Christopher Cao; Daniel Wang; Caroline Chung; David Tian; Andreas Rimner; James Huang; David R Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2018-09-15       Impact factor: 5.209

9.  The relationship between nutritional status and prognosis in patients with locally advanced and advanced stage lung cancer.

Authors:  Busra Gul; Selma Metintas; Guntulu Ak; Senay Yilmaz; Muzaffer Metintas
Journal:  Support Care Cancer       Date:  2020-10-30       Impact factor: 3.603

10.  Real-world outcomes in patients with unresected stage III non-small cell lung cancer.

Authors:  Kellie J Ryan; Karen E Skinner; Ancilla W Fernandes; Rajeshwari S Punekar; Melissa Pavilack; Mark S Walker; Noam A VanderWalde
Journal:  Med Oncol       Date:  2019-01-31       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.